// pharmacovigilance
Pharmacovigilance
Lab Curriculum.
STARTING SOON
BUG FOUND: learners who know drug safety terms, but cannot handle a real adverse-event case correctly.
$ step-01 brushup // weeks 1–2 — Topics taught:
- Drug safety basics: adverse events, seriousness, and expectedness concepts.
- Case basics: patient, drug, event, reporter, and timeline.
- Causality assessment basics.
- MedDRA coding concepts for events and drugs.
- Reporting basics: what must be reported, to whom, and by when.
- Follow-up basics: what information is missing, and how to ask for it.
$ step-02 debug // weeks 3–4 — Production Debugging. Tools: sample adverse-event cases, safety database concepts, reporting templates.
- BUG #1: Adverse-event error: a case is coded to the wrong event term — find it, correct it, document the reason.
- BUG #2: Incomplete case: a serious case lacks key data — identify what is missing, draft a follow-up request.
- BUG #3: Wrong causality / seriousness assessment — reassess with evidence, document the reasoning.
- BUG #4: Duplicate case: the same event is reported twice — detect the duplicate, merge / link correctly, document it.
$ step-03 navigate // weeks 5–7 — Codebase / System Navigation:
- Navigate a safety database and cases: trace a case from report to assessment to submission.
- Follow up missing data across multiple cases, prioritising by seriousness.
- Audit a case set for coding, causality, and timeliness errors; rank by risk.
- Review a peer's case assessment for evidence, consistency, and completeness.
$ step-04 ship // weeks 8–9 — Shipping Features: capstone — audited safety-case reports with a follow-up plan, presented as if to a safety reviewer.
$ ship → PROOF — exact output: audited safety-case reports, follow-up plan, and an error summary.
$ run --lab pharmacovigilance → ✓ SHIPPED, job-ready
₹9,999 / lab
✓ 9 weeks · ✓ cohort 30
What ₹9,999 buys: brushup → production debugging → codebase navigation → shipping features, reviewed by mentors, ending with work you can show to a hiring manager.